Innovation

Medical laboratory scientist, Aniela Sobel, tests serology samples from the Novavax phase 3 Covid-19 clinical vaccine trial at the UW Medicine Retrovirology Research Lab at Harborview Medical Center on February 12 (Photo by Karen Ducey/Getty Images)
Caption
Medical laboratory scientist, Aniela Sobel, tests serology samples from the Novavax phase 3 Covid-19 clinical vaccine trial at the UW Medicine Retrovirology Research Lab at Harborview Medical Center on February 12 (Photo by Karen Ducey/Getty Images)
Commentary
Adam Mossoff
Adam Mossoff
Chair, Forum for Intellectual Property and Senior Fellow
4 Min Read
Researchers at the UW Medicine Retrovirology Lab at Harborview Medical Center work on samples from the Novavax phase 3 Covid-19 clinical vaccine trials on February 12, 2021 in Seattle, Washington. (Photo by Karen Ducey/Getty Images)
Caption
Researchers at the UW Medicine Retrovirology Lab at Harborview Medical Center work on samples from the Novavax phase 3 Covid-19 clinical vaccine trials on February 12, 2021 in Seattle, Washington. (Photo by Karen Ducey/Getty Images)
Commentary
Adam Mossoff
Adam Mossoff
Chair, Forum for Intellectual Property and Senior Fellow
3 Min Read
stay informed putin
Stay Informed.

Sign up for our newsletter and get the latest insights and analysis you won’t find anywhere else tailored to the topics that matter to you.